Jul. 27 at 7:19 PM
$SSKN (1/2) This came to may attention after some DD.
What do I like?
- PR in May 2025: CPT codes 96920–96922 have been revised by the AMA. This change means significant growth potential for SSKN through higher reimbursement rates, more treatments, and broader market presence.
- Insiders hold approx. 39% of the shares. Uri Geiger, director and more than 10% owner of SSKN, purchased 230k common shares directly at a price of
$3.14 per share exactly one year ago. Following the purchase, he is indirectly attributed 1,441,835 shares.
- Tutes hold approx. 30%.
Cash/share is
$1.88, which is almost equal to the current share price. Cash balance as of March 31, 2025: 7.8 M, cash burn was reduced to USD 749k in Q1 (previous year: 1.55 M), which shows better capital discipline.
- Analysts say strong buy, but that's only one analyst – and I don't pay much attention to that anyway. But still better than a sell recommendation, right?
Short float: 0.14%, so shorts don't seem to bet against this stock.
...
